SCHEMBL22717397

SCHEMBL22717397

COC(=O)c1cc(C)ncc1-c1ccccc1OC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLQ O75417 2/20 0.53
▸ VDR P11473 1/20 0.48
▸ BACE1 P56817 1/20 0.48
▸ MAPT P10636 5/20 0.48
▸ HSP90AA1 P07900 2/20 0.48
▸ HTT P42858 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ KMT2A Q03164 3/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ ALDH1A1 P00352 6/20 0.44
▸ HSD17B10 Q99714 5/20 0.44
▸ CYP1A2 P05177 4/20 0.44
▸ TSHR P16473 3/20 0.44
▸ CYP2C19 P33261 3/20 0.44
▸ CYP2D6 P10635 2/20 0.44
▸ ALOX15 P16050 2/20 0.44
▸ CYP3A4 P08684 2/20 0.44
▸ GAA P10253 2/20 0.43
▸ HPGD P15428 2/20 0.43
▸ CLK4 Q9HAZ1 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30017905 0.89 POLQ (0.61) POLQVDRBACE1MAPTHSP90AA1
SCHEMBL31019111 0.89 POLQ (0.61) POLQVDRBACE1MAPTHSP90AA1
SCHEMBL22717466 0.89 POLQ (0.61) POLQVDRBACE1MAPTHSP90AA1
SCHEMBL22732085 0.87 POLQ (0.51) POLQHSP90AA1HTTSMN1; SMN2SLC6A3
SCHEMBL22717582 0.85 VDR (0.46) POLQVDRBACE1MAPTHSP90AA1
SCHEMBL29575360 0.85 VDR (0.46) POLQVDRBACE1MAPTHSP90AA1
SCHEMBL29574586 0.85 SLC6A3 (0.47) POLQVDRMAPTHSP90AA1HTT
SCHEMBL22717267 0.85 ALDH1A1 (0.50) POLQVDRMAPTHSP90AA1HTT
SCHEMBL22717423 0.85 SLC6A3 (0.47) POLQVDRMAPTHSP90AA1HTT
SCHEMBL22717445 0.84 ALDH1A1 (0.47) POLQVDRBACE1MAPTHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260049074-A1 THIADIAZOLYL DERIVATIVES IDEAYA BIOSCIENCES, INC. (US) 2026-02-19 — — US disclosed
US-12509454-B2 Thiadiazolyl derivatives IDEAYA BIOSCIENCES, INC. (US) 2025-12-30 — — US disclosed
EP-3976608-B1 THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS IDEAYA BIOSCIENCES INC (US) 2023-11-08 — — EP disclosed
EP-3976608-B1 THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS IDEAYA BIOSCIENCES INC (US) 2023-11-08 — — EP disclosed
US-20230078112-A1 THIADIAZOLYL DERIVATIVES IDEAYA BIOSCIENCES, INC. 2023-03-16 — — US disclosed
EP-3976608-A1 THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS Ideaya Biosciences, Inc. (US) 2022-04-06 — — EP disclosed
CN-114127062-A Thiadiazolyl derivatives as inhibitors of DNA polymerase Theta 伊迪亚生物科学有限公司 2022-03-01 — — CN disclosed
WO-2020243459-A1 THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS IDEAYA BIOSCIENCES, INC. (US) 2020-12-03 — — WO disclosed
WO-2020243459-A1 THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS IDEAYA BIOSCIENCES, INC. (US) 2020-12-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260049074-A1 THIADIAZOLYL DERIVATIVES POLH, POLM, POLD1 POLQ 4/4885VDR 1100/4885BACE1 3002/4885
US-20230078112-A1 THIADIAZOLYL DERIVATIVES POLQ, POLK, POLA1 POLQ 1/4885VDR 1826/4885BACE1 1945/4885
US-12509454-B2 Thiadiazolyl derivatives POLD1, POLQ, DNA2 POLQ 2/4885VDR 1750/4885BACE1 1184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback